Increased circulating resistin levels in early-onset breast cancer patients of normal body mass index correlate with lymph node negative involvement and longer disease free survival: a multi-center POSH cohort serum proteomics study.
Name:
s13058-018-0938-6.pdf
Size:
1.763Mb
Format:
PDF
Description:
Open access full text article
Authors
Zeidan, BManousopoulou, A
Garay-Baquero, D
White, C
Larkin, S
Potter, K
Roumeliotis, T
Papachristou, E
Copson, E
Cutress, R
Beers, S
Eccles, D
Townsend, Paul A
Garbis, S
Affiliation
Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UKIssue Date
2018-03-22
Metadata
Show full item recordAbstract
Early-onset breast cancer (EOBC) affects about one in 300 women aged 40 years or younger and is associated with worse outcomes than later onset breast cancer. This study explored novel serum proteins as surrogate markers of prognosis in patients with EOBC.Citation
Increased circulating resistin levels in early-onset breast cancer patients of normal body mass index correlate with lymph node negative involvement and longer disease free survival: a multi-center POSH cohort serum proteomics study. 2018, 20(1): 19 Breast Cancer ResJournal
Breast Cancer ResearchDOI
10.1186/s13058-018-0938-6PubMed ID
29566726Type
ArticleLanguage
enISSN
1465-542Xae974a485f413a2113503eed53cd6c53
10.1186/s13058-018-0938-6
Scopus Count
Collections
Related articles
- Interleukin 15 and Eotaxin correlate with the outcome of breast cancer patients vice versa independent of CTC status.
- Authors: Vilsmaier T, Heidegger HH, Schröder L, Trapp E, Zehni AZ, Rack B, Janni W, Mahner S, Weissenbacher T, Jeschke U, Mumm JN, SUCCESS Study Group
- Issue date: 2021 Jan
- Elevated Resistin Gene Expression in African American Estrogen and Progesterone Receptor Negative Breast Cancer.
- Authors: Vallega KA, Liu N, Myers JS, Yu K, Sang QX
- Issue date: 2016
- Outcome after neoadjuvant chemotherapy in estrogen receptor-positive and progesterone receptor-negative breast cancer patients: a pooled analysis of individual patient data from ten prospectively randomized controlled neoadjuvant trials.
- Authors: van Mackelenbergh MT, Denkert C, Nekljudova V, Karn T, Schem C, Marmé F, Stickeler E, Jackisch C, Hanusch C, Huober J, Fasching PA, Blohmer JU, Kümmel S, Müller V, Schneeweiss A, Untch M, von Minckwitz G, Weber KE, Loibl S
- Issue date: 2018 Jan
- Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes.
- Authors: Koca E, Kuzan TY, Dizdar O, Babacan T, Sahin I, Ararat E, Altundag K
- Issue date: 2013
- Combined High Resistin and EGFR Expression Predicts a Poor Prognosis in Breast Cancer.
- Authors: Zeng Y, Tang CH, Wang Y, Lu HJ, Huang BF, Wang Q, Shao JK, Jin LL, Wang CQ, Teng LS
- Issue date: 2020